ID

19262

Descripción

A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.; ODM derived from: https://clinicaltrials.gov/show/NCT00086320

Link

https://clinicaltrials.gov/show/NCT00086320

Palabras clave

Versiones (2)
  1. 16/12/16 16/12/16 -
  2. 16/12/16 16/12/16 -
Subido en

16 de diciembre de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Schizophrenia NCT00086320

Inglés

Eligibility Schizophrenia NCT00086320

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
dsm-iv diagnosis of schizophrenia at least 1 year before screening
Descripción

Schizophrenia disease length

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0036341
UMLS CUI [1,2]
C0872146
experiencing an acute schizophrenic episode with a total panss score between 70 and 120
Descripción

schizophrenic episode Positive and negative syndrome scale

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1396838
UMLS CUI [1,2]
C0451383
agree to be hospitalized for a minimum of 14 days at the start of the study
Descripción

Hospitalization Duration Agreement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C0449238
UMLS CUI [1,3]
C0680240
capable of administering study medication themselves or have assistance with study medication administration consistently available throughout the study
Descripción

Investigational New Drugs Self-Administered Ability | Investigational New Drugs Administration Assistance Available

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C1519231
UMLS CUI [1,3]
C0085732
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C1533734
UMLS CUI [2,3]
C1269765
UMLS CUI [2,4]
C0470187
resided at the same address continuously for at least 30 days prior to screening
Descripción

residence Address Same Continuous

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0237096
UMLS CUI [1,2]
C1442065
UMLS CUI [1,3]
C0445247
UMLS CUI [1,4]
C0549178
able and willing to fill out self administered questionnaires
Descripción

Questionnaires Self-Administered Completion

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0034394
UMLS CUI [1,2]
C1519231
UMLS CUI [1,3]
C0205197
washout of antiparkinsonian medications, beta-blockers
Descripción

Washout Antiparkinson Agents | Washout Adrenergic beta-1 Receptor Antagonists

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1710661
UMLS CUI [1,2]
C0003405
UMLS CUI [2,1]
C1710661
UMLS CUI [2,2]
C0304516
antiepileptics, lithium 3 days prior to the start of the run-in phase
Descripción

Antiepileptic Agents | Lithium

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0003299
UMLS CUI [2]
C0023870
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
dsm-iv axis i diagnosis other than schizophrenia
Descripción

Axis I diagnosis | Schizophrenia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0270287
UMLS CUI [2]
C0036341
dsm-iv diagnosis of substance dependence within 6 months prior to screening (nicotine and caffeine dependence are not exclusionary)
Descripción

Substance Dependence | Nicotine Dependence | Caffeine dependence

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0038580
UMLS CUI [2]
C0028043
UMLS CUI [3]
C1386553
preexisting severe gastrointestinal narrowing (pathologic or iatrogenic)
Descripción

Gastrointestinal stenosis Pathologic Severe Pre-existing | Gastrointestinal stenosis Iatrogenic Severe Pre-existing

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0521587
UMLS CUI [1,2]
C1521733
UMLS CUI [1,3]
C0205082
UMLS CUI [1,4]
C2347662
UMLS CUI [2,1]
C0521587
UMLS CUI [2,2]
C0439669
UMLS CUI [2,3]
C0205082
UMLS CUI [2,4]
C2347662
injection of a depot antipsychotic within 120 days before screening, or use of paliperidone palmitate within 10 months before screening
Descripción

Injection of depot antipsychotic agent | paliperidone palmitate

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2585377
UMLS CUI [2]
C2719626
previous history of lack of response to risperidone when acutely psychotic
Descripción

Risperidone Psychotic Disorder | Poor response to treatment

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0073393
UMLS CUI [1,2]
C0033975
UMLS CUI [2]
C1320680
history of neuroleptic malignant syndrome
Descripción

Neuroleptic Malignant Syndrome

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0027849
significant risk of suicidal or violent behavior
Descripción

Suicidal behavior Risk Significant | Physical aggression Risk Significant

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1760428
UMLS CUI [1,2]
C0035647
UMLS CUI [1,3]
C0750502
UMLS CUI [2,1]
C0424323
UMLS CUI [2,2]
C0035647
UMLS CUI [2,3]
C0750502
Volver a la parte superior de la página

Similar models

Eligibility Schizophrenia NCT00086320

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Schizophrenia disease length
Item
dsm-iv diagnosis of schizophrenia at least 1 year before screening
boolean
C0036341 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
schizophrenic episode Positive and negative syndrome scale
Item
experiencing an acute schizophrenic episode with a total panss score between 70 and 120
boolean
C1396838 (UMLS CUI [1,1])
C0451383 (UMLS CUI [1,2])
Hospitalization Duration Agreement
Item
agree to be hospitalized for a minimum of 14 days at the start of the study
boolean
C0019993 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0680240 (UMLS CUI [1,3])
Investigational New Drugs Self-Administered Ability | Investigational New Drugs Administration Assistance Available
Item
capable of administering study medication themselves or have assistance with study medication administration consistently available throughout the study
boolean
C0013230 (UMLS CUI [1,1])
C1519231 (UMLS CUI [1,2])
C0085732 (UMLS CUI [1,3])
C0013230 (UMLS CUI [2,1])
C1533734 (UMLS CUI [2,2])
C1269765 (UMLS CUI [2,3])
C0470187 (UMLS CUI [2,4])
residence Address Same Continuous
Item
resided at the same address continuously for at least 30 days prior to screening
boolean
C0237096 (UMLS CUI [1,1])
C1442065 (UMLS CUI [1,2])
C0445247 (UMLS CUI [1,3])
C0549178 (UMLS CUI [1,4])
Questionnaires Self-Administered Completion
Item
able and willing to fill out self administered questionnaires
boolean
C0034394 (UMLS CUI [1,1])
C1519231 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
Washout Antiparkinson Agents | Washout Adrenergic beta-1 Receptor Antagonists
Item
washout of antiparkinsonian medications, beta-blockers
boolean
C1710661 (UMLS CUI [1,1])
C0003405 (UMLS CUI [1,2])
C1710661 (UMLS CUI [2,1])
C0304516 (UMLS CUI [2,2])
Antiepileptic Agents | Lithium
Item
antiepileptics, lithium 3 days prior to the start of the run-in phase
boolean
C0003299 (UMLS CUI [1])
C0023870 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Axis I diagnosis | Schizophrenia
Item
dsm-iv axis i diagnosis other than schizophrenia
boolean
C0270287 (UMLS CUI [1])
C0036341 (UMLS CUI [2])
Substance Dependence | Nicotine Dependence | Caffeine dependence
Item
dsm-iv diagnosis of substance dependence within 6 months prior to screening (nicotine and caffeine dependence are not exclusionary)
boolean
C0038580 (UMLS CUI [1])
C0028043 (UMLS CUI [2])
C1386553 (UMLS CUI [3])
Gastrointestinal stenosis Pathologic Severe Pre-existing | Gastrointestinal stenosis Iatrogenic Severe Pre-existing
Item
preexisting severe gastrointestinal narrowing (pathologic or iatrogenic)
boolean
C0521587 (UMLS CUI [1,1])
C1521733 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C2347662 (UMLS CUI [1,4])
C0521587 (UMLS CUI [2,1])
C0439669 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C2347662 (UMLS CUI [2,4])
Injection of depot antipsychotic agent | paliperidone palmitate
Item
injection of a depot antipsychotic within 120 days before screening, or use of paliperidone palmitate within 10 months before screening
boolean
C2585377 (UMLS CUI [1])
C2719626 (UMLS CUI [2])
Risperidone Psychotic Disorder | Poor response to treatment
Item
previous history of lack of response to risperidone when acutely psychotic
boolean
C0073393 (UMLS CUI [1,1])
C0033975 (UMLS CUI [1,2])
C1320680 (UMLS CUI [2])
Neuroleptic Malignant Syndrome
Item
history of neuroleptic malignant syndrome
boolean
C0027849 (UMLS CUI [1])
Suicidal behavior Risk Significant | Physical aggression Risk Significant
Item
significant risk of suicidal or violent behavior
boolean
C1760428 (UMLS CUI [1,1])
C0035647 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,3])
C0424323 (UMLS CUI [2,1])
C0035647 (UMLS CUI [2,2])
C0750502 (UMLS CUI [2,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial